Literature DB >> 11207648

Immune complex processing in C1q-deficient mice.

J T Nash1, P R Taylor, M Botto, P J Norsworthy, K A Davies, M J Walport.   

Abstract

Complement and Fcgamma receptors are known to mediate the processing of immune complexes (IC), and abnormalities in these mechanisms may predispose to the development of lupus. We explored the processing of IC in mice deficient in complement component C1q. 125I-labelled IC comprising Hepatitis B surface antigen (HBsAg)/human anti-HBsAg (HBsAg/Ab) were injected intravenously and the sites of IC clearance determined by direct counting of organ uptake at various time points. The liver and spleen were the main sites of IC uptake in all mice. The splenic uptake of IC was significantly reduced in the C1q-deficient mice compared with the control mice. C1q-deficient mice also exhibited an initial accelerated hepatic uptake of IC similar to that seen in human subjects with hypocomplementaemia. The hepatic localization of IC at later time points was similar in both groups of mice. These data in mice are consistent with previous observations in humans that confirm that the classical pathway of complement plays an important role in the appropriate processing of IC in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207648      PMCID: PMC1905984          DOI: 10.1046/j.1365-2249.2001.01459.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  48 in total

1.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.

Authors:  J Wu; J C Edberg; P B Redecha; V Bansal; P M Guyre; K Coleman; J E Salmon; R P Kimberly
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.

Authors:  J A Schifferli; Y C Ng; J Estreicher; M J Walport
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

3.  Clearance and organ localization of small DNA anti-DNA immune complexes in mice.

Authors:  W Emlen; G Burdick
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

4.  Difference in clearance kinetics of particulate immune complexes and soluble aggregates of IgG in vivo.

Authors:  R Veerhuis; M C Krol; L A van Es; M R Daha
Journal:  Clin Immunol Immunopathol       Date:  1986-12

5.  A simple numerical method for the construction of isokinetic sucrose density gradients, and their application to the characterisation of immunoglobulin complexes.

Authors:  P Johns; D R Stanworth
Journal:  J Immunol Methods       Date:  1976-03       Impact factor: 2.303

6.  Primate erythrocyte-immune complex-clearing mechanism.

Authors:  J B Cornacoff; L A Hebert; W L Smead; M E VanAman; D J Birmingham; F J Waxman
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

7.  On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2.

Authors:  P W Parren; P A Warmerdam; L C Boeije; J Arts; N A Westerdaal; A Vlug; P J Capel; L A Aarden; J G van de Winkel
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

8.  Tissue distribution of intravenously injected dinitrophenylated human serum albumin. Effects of specific IgG and IgA antibodies.

Authors:  T Skogh
Journal:  Scand J Immunol       Date:  1982-12       Impact factor: 3.487

9.  Deficiency of complement component C3 is associated with accelerated removal of soluble 123I-labelled aggregates of IgG from the circulation.

Authors:  C Halma; M R Daha; J A Camps; J H Evers-Schouten; E K Pauwels; E s Van
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

10.  Clearance of circulating DNA-anti-DNA immune complexes in mice.

Authors:  W Emlen; M Mannik
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

View more
  11 in total

1.  Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.

Authors:  Judith M H de Jong; Danita H Schuurhuis; Andreea Ioan-Facsinay; Mick M Welling; Marcel G M Camps; Ellen I H van der Voort; Tom W J Huizinga; Ferry Ossendorp; J Sjef Verbeek; René E M Toes
Journal:  Immunology       Date:  2006-09-21       Impact factor: 7.397

Review 2.  B cells in glomerulonephritis: focus on lupus nephritis.

Authors:  Menna R Clatworthy; Kenneth G C Smith
Journal:  Semin Immunopathol       Date:  2007-10-18       Impact factor: 9.623

3.  Both Fcgamma and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions in vitro.

Authors:  A L Hepburn; J C Mason; S Wang; C J Shepherd; O Florey; D O Haskard; K A Davies
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

4.  C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes.

Authors:  Deanna M Santer; Brian E Hall; Thaddeus C George; Stephanie Tangsombatvisit; Chih Long Liu; Peter D Arkwright; Keith B Elkon
Journal:  J Immunol       Date:  2010-09-15       Impact factor: 5.422

5.  Dnase1l3 deficiency in lupus-prone MRL and NZB/W F1 mice.

Authors:  A Wilber; T P O'Connor; M L Lu; A Karimi; M C Schneider
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

6.  Malaria inhibits surface expression of complement receptor 1 in monocytes/macrophages, causing decreased immune complex internalization.

Authors:  Cristina Fernandez-Arias; Jean Pierre Lopez; Jean Nikolae Hernandez-Perez; Maria Dolores Bautista-Ojeda; Oralee Branch; Ana Rodriguez
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

7.  Monocytosis and accelerated activation of lymphocytes in C1q-deficient autoimmune-prone mice.

Authors:  Marten Trendelenburg; Anthony P Manderson; Liliane Fossati-Jimack; Mark J Walport; Marina Botto
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

8.  Continual low-level activation of the classical complement pathway.

Authors:  A P Manderson; M C Pickering; M Botto; M J Walport; C R Parish
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

Review 9.  Complement and its role in protection and pathogenesis of flavivirus infections.

Authors:  Panisadee Avirutnan; Erin Mehlhop; Michael S Diamond
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

Review 10.  Engineering of Fc Multimers as a Protein Therapy for Autoimmune Disease.

Authors:  Elizabeth A Fitzpatrick; Jin Wang; S E Strome
Journal:  Front Immunol       Date:  2020-03-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.